These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1401 related articles for article (PubMed ID: 29749524)
21. Deregulation of the Hippo pathway in mouse mammary stem cells promotes mammary tumorigenesis. Li H; Gumbiner BM Mamm Genome; 2016 Dec; 27(11-12):556-564. PubMed ID: 27601049 [TBL] [Abstract][Full Text] [Related]
22. Role of the Hippo-YAP/TAZ Pathway in Epithelioid Hemangioendothelioma and its Potential as a Therapeutic Target. Suto H Anticancer Res; 2024 Oct; 44(10):4147-4153. PubMed ID: 39348982 [TBL] [Abstract][Full Text] [Related]
23. Endothelin Promotes Colorectal Tumorigenesis by Activating YAP/TAZ. Wang Z; Liu P; Zhou X; Wang T; Feng X; Sun YP; Xiong Y; Yuan HX; Guan KL Cancer Res; 2017 May; 77(9):2413-2423. PubMed ID: 28249901 [TBL] [Abstract][Full Text] [Related]
24. YAP/TAZ Initiates Gastric Tumorigenesis via Upregulation of MYC. Choi W; Kim J; Park J; Lee DH; Hwang D; Kim JH; Ashktorab H; Smoot D; Kim SY; Choi C; Koh GY; Lim DS Cancer Res; 2018 Jun; 78(12):3306-3320. PubMed ID: 29669762 [TBL] [Abstract][Full Text] [Related]
25. YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role. Van Haele M; Moya IM; Karaman R; Rens G; Snoeck J; Govaere O; Nevens F; Verslype C; Topal B; Monbaliu D; Halder G; Roskams T Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717258 [TBL] [Abstract][Full Text] [Related]
26. Thromboxane A2 Activates YAP/TAZ Protein to Induce Vascular Smooth Muscle Cell Proliferation and Migration. Feng X; Liu P; Zhou X; Li MT; Li FL; Wang Z; Meng Z; Sun YP; Yu Y; Xiong Y; Yuan HX; Guan KL J Biol Chem; 2016 Sep; 291(36):18947-58. PubMed ID: 27382053 [TBL] [Abstract][Full Text] [Related]
27. Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis. Wu LMN; Deng Y; Wang J; Zhao C; Wang J; Rao R; Xu L; Zhou W; Choi K; Rizvi TA; Remke M; Rubin JB; Johnson RL; Carroll TJ; Stemmer-Rachamimov AO; Wu J; Zheng Y; Xin M; Ratner N; Lu QR Cancer Cell; 2018 Feb; 33(2):292-308.e7. PubMed ID: 29438698 [TBL] [Abstract][Full Text] [Related]
28. WWC1 and NF2 Prevent the Development of Intrahepatic Cholangiocarcinoma by Regulating YAP/TAZ Activity through LATS in Mice. Park J; Kim JS; Nahm JH; Kim SK; Lee DH; Lim DS Mol Cells; 2020 May; 43(5):491-499. PubMed ID: 32451369 [TBL] [Abstract][Full Text] [Related]
29. Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis. Nishina H Cancer Sci; 2022 Jun; 113(6):1900-1908. PubMed ID: 35349740 [TBL] [Abstract][Full Text] [Related]
30. TAZ and YAP are frequently activated oncoproteins in sarcomas. Fullenkamp CA; Hall SL; Jaber OI; Pakalniskis BL; Savage EC; Savage JM; Ofori-Amanfo GK; Lambertz AM; Ivins SD; Stipp CS; Miller BJ; Milhem MM; Tanas MR Oncotarget; 2016 May; 7(21):30094-108. PubMed ID: 27129148 [TBL] [Abstract][Full Text] [Related]
31. dNTP metabolism links mechanical cues and YAP/TAZ to cell growth and oncogene-induced senescence. Santinon G; Brian I; Pocaterra A; Romani P; Franzolin E; Rampazzo C; Bicciato S; Dupont S EMBO J; 2018 Jun; 37(11):. PubMed ID: 29650681 [TBL] [Abstract][Full Text] [Related]
32. The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer. Di Benedetto A; Mottolese M; Sperati F; Ercolani C; Di Lauro L; Pizzuti L; Vici P; Terrenato I; Sperduti I; Shaaban AM; Sundara-Rajan S; Barba M; Speirs V; De Maria R; Maugeri-Saccà M Oncotarget; 2016 Jul; 7(28):43188-43198. PubMed ID: 27248471 [TBL] [Abstract][Full Text] [Related]
33. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Moroishi T; Park HW; Qin B; Chen Q; Meng Z; Plouffe SW; Taniguchi K; Yu FX; Karin M; Pan D; Guan KL Genes Dev; 2015 Jun; 29(12):1271-84. PubMed ID: 26109050 [TBL] [Abstract][Full Text] [Related]
34. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis. Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988 [TBL] [Abstract][Full Text] [Related]
35. Common and Distinctive Functions of the Hippo Effectors Taz and Yap in Skeletal Muscle Stem Cell Function. Sun C; De Mello V; Mohamed A; Ortuste Quiroga HP; Garcia-Munoz A; Al Bloshi A; Tremblay AM; von Kriegsheim A; Collie-Duguid E; Vargesson N; Matallanas D; Wackerhage H; Zammit PS Stem Cells; 2017 Aug; 35(8):1958-1972. PubMed ID: 28589555 [TBL] [Abstract][Full Text] [Related]
36. Establishment of transgenic lines to monitor and manipulate Yap/Taz-Tead activity in zebrafish reveals both evolutionarily conserved and divergent functions of the Hippo pathway. Miesfeld JB; Link BA Mech Dev; 2014 Aug; 133():177-88. PubMed ID: 24560909 [TBL] [Abstract][Full Text] [Related]
37. YAP and TAZ Take Center Stage in Cancer. Zhang K; Qi HX; Hu ZM; Chang YN; Shi ZM; Han XH; Han YW; Zhang RX; Zhang Z; Chen T; Hong W Biochemistry; 2015 Nov; 54(43):6555-66. PubMed ID: 26465056 [TBL] [Abstract][Full Text] [Related]
38. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway. Chen M; Wang M; Xu S; Guo X; Jiang J Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204 [TBL] [Abstract][Full Text] [Related]
39. Arsenic-induced cutaneous hyperplastic lesions are associated with the dysregulation of Yap, a Hippo signaling-related protein. Li C; Srivastava RK; Elmets CA; Afaq F; Athar M Biochem Biophys Res Commun; 2013 Sep; 438(4):607-12. PubMed ID: 23942117 [TBL] [Abstract][Full Text] [Related]
40. A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy. Pobbati AV; Hong W Theranostics; 2020; 10(8):3622-3635. PubMed ID: 32206112 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]